Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Versatis in postherpetic neuralgia
NCT03745404Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Apr 2003
- Primary completion
- Jun 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of lidocaine in postherpetic neuralgia (PHN), sponsored by Grünenthal GmbH. Started Apr 2003; status: completed.
02
Drugs
lidocaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT03745404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03745404.